Market Research Logo

Alexza Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review

Alexza Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Alexza Pharmaceuticals, Inc. (Alexza) is a pharmaceutical company, which carries out research and development, and commercializes proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system, which is the foundation for Adasuve (loxapine), and all other product candidates. The company’s only lead product Adasuve is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder. The company’s product candidates consist of AZ-002 (Staccato alprazolam) for acute repetitive seizures and AZ-007 (Staccato zaleplon) for insomnia. Alexza is headquartered in Mountain View, California, the US.

Alexza Pharmaceuticals, Inc. Key Recent Developments

Jul 02, 2016: Delisting of Securities of Alexza Pharmaceuticals from The Nasdaq Stock Market
May 11, 2016: Alexza Reports 2016 First Quarter Financial Results
Mar 28, 2016: Alexza Reports Fourth Quarter and Year End 2015 Financial Results
Mar 09, 2016: Alexza Pharmaceuticals Receives Positive Nasdaq Listing Determination
Dec 22, 2015: Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing with NASDAQ Listing Qualifications Panel

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Alexza Pharmaceuticals, Inc. - Key Facts
Alexza Pharmaceuticals, Inc. - Key Employees
Alexza Pharmaceuticals, Inc. - Key Employee Biographies
Alexza Pharmaceuticals, Inc. - Major Products and Services
Alexza Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
Alexza Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Alexza Pharmaceuticals, Inc., Pipeline Products by Development Phase
Alexza Pharmaceuticals, Inc. - History
Alexza Pharmaceuticals, Inc. - Company Statement
Alexza Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Alexza Pharmaceuticals, Inc. - Business Description
Alexza Pharmaceuticals, Inc. - Corporate Strategy
Alexza Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Alexza Pharmaceuticals, Inc. - Strengths
Strength - Focused R&D Activities
Strength - Lead Product: Adasuve
Strength - Proprietary Staccato Technology
Alexza Pharmaceuticals, Inc. - Weaknesses
Weakness - Reliance on Third Parties
Weakness - History of Operating Losses
Alexza Pharmaceuticals, Inc. - Opportunities
Opportunity - Pipeline Products
Opportunity - Market Potential – Central Nervous System
Opportunity - Merger Agreement with Ferrer
Alexza Pharmaceuticals, Inc. - Threats
Threat - Government Regulations
Threat - Intense Competition
Threat - Cost Containment Pressures
Alexza Pharmaceuticals, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Alexza Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 02, 2016: Delisting of Securities of Alexza Pharmaceuticals from The Nasdaq Stock Market
May 11, 2016: Alexza Reports 2016 First Quarter Financial Results
Mar 28, 2016: Alexza Reports Fourth Quarter and Year End 2015 Financial Results
Mar 09, 2016: Alexza Pharmaceuticals Receives Positive Nasdaq Listing Determination
Dec 22, 2015: Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing with NASDAQ Listing Qualifications Panel
Nov 05, 2015: Alexza Reports 2015 Third Quarter Financial Results
Oct 02, 2015: Alexza Pharmaceuticals Announces Management Promotions
Aug 06, 2015: Alexza Reports 2015 Second Quarter Financial Results
May 06, 2015: Alexza Reports 2015 First Quarter Financial Results
Apr 29, 2015: Alexza Pharmaceuticals Announces Management Promotions
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Alexza Pharmaceuticals, Inc., Key Facts
Alexza Pharmaceuticals, Inc., Key Employees
Alexza Pharmaceuticals, Inc., Key Employee Biographies
Alexza Pharmaceuticals, Inc., Major Products and Services
Alexza Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
Alexza Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
Alexza Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
Alexza Pharmaceuticals, Inc., History
Alexza Pharmaceuticals, Inc., Subsidiaries
Alexza Pharmaceuticals, Inc., Key Competitors
Alexza Pharmaceuticals, Inc., Ratios based on current share price
Alexza Pharmaceuticals, Inc., Annual Ratios
Alexza Pharmaceuticals, Inc., Interim Ratios
Alexza Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Alexza Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Alexza Pharmaceuticals, Inc., Pipeline Products by Development Phase
Alexza Pharmaceuticals, Inc., Performance Chart (2011 - 2015)
Alexza Pharmaceuticals, Inc., Ratio Charts
Alexza Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alexza Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report